About Emcay
Emcay is a company based in New York (United States) founded in 2013 was acquired by Fingerpaint in July 2022. Emcay offers products and services including Branding Services, Medical Communications, and Medical Affairs. Emcay operates in a competitive market with competitors including Sayre Therapeutics, Zevra, Supreme Optimization, Ethosh and Andira, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Fingerpaint
(Jul 14, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emcay
Emcay offers a comprehensive portfolio of products and services, including Branding Services, Medical Communications, and Medical Affairs.
Offers strategic branding for healthcare through naming and design.
Provides communications expertise for pharmaceutical industry needs.
Delivers omnichannel engagement strategies for medical sectors.
Funding Insights of Emcay
Detailed funding history for Emcay
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Emcay
Emcay has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fingerpaint.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare information and content are delivered through an online platform.
|
Locked | Locked | Locked |
Investor details for Emcay
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emcay
Investment portfolio details for Emcay
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emcay
Detailed financials for Emcay
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emcay Comparisons
Peer comparison for Emcay
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emcay
Emcay operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sayre Therapeutics, Zevra, Supreme Optimization, Ethosh and Andira, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Access to therapies for rare and life-threatening diseases is provided.
|
|
| Locked | Locked | Locked |
Marketing services are provided to biopharma companies.
|
|
| Locked | Locked | Locked |
Digital marketing services are offered to the life sciences sector.
|
|
| Locked | Locked | Locked |
Provider of digital experience and marketing services to health-tech and life-sciences organizations
|
|
| Locked | Locked | Locked |
Digital pharmacotherapeutic platform for providers
|
|
| Locked | Locked | Locked |
Marketing software for pharmacies is provided by Techizer.
|
Detailed competitors of Emcay
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emcay
Complete news archive for Emcay
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emcay
Emcay was founded in 2013.
Emcay is headquartered in New York, United States. It is registered at New York, New York, United States.
Emcay was established in 2013 and is based in New York, United States. Operations focus on the pharmaceutical sector, where branding, digital marketing, and advertising services are delivered. These services support client needs in promotional strategies and online presence. The company operates through its domain emcay.net, serving businesses in this specialized industry across relevant geographies.
Emcay's top competitors include Zevra, Sayre Therapeutics and Ethosh.
Emcay offers Branding Services, Medical Communications, and Medical Affairs.
Emcay has 1 investor. Key investors include Fingerpaint.